Ultragenyx Pharmaceutical Inc. Stock Forecast

RARE Signals & Forecast

The Ultragenyx Pharmaceutical Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $38.82 and $36.12. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, November 17, 2023, and so far it has fallen -2.15%. Further fall is indicated until a new bottom pivot has been found.

Get your hands on a piece of history – invest in multi-million dollar paintings from $10k with Masterworks.

Support, Risk & Stop-loss for Ultragenyx Pharmaceutical Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $37.02 and $33.45. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Ultragenyx Pharmaceutical Inc. finds support just below today's level at $37.02. If this is broken, then the next support from accumulated volume will be at $33.45 and $31.73.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.39 between high and low, or 3.61%. For the last week, the stock has had daily average volatility of 3.46%.

Our recommended stop-loss: $37.62 (-3.80%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 7 days ago.)

Trading Expectations (RARE) For The Upcoming Trading Day Of Thursday 30th

For the upcoming trading day on Thursday, 30th we expect Ultragenyx Pharmaceutical Inc. to open at $39.17, and during the day (based on 14 day Average True Range), to move between $37.34 and $40.88, which gives a possible trading interval of +/-$1.77 (+/-4.52%) up or down from last closing price. If Ultragenyx Pharmaceutical Inc. takes out the full calculated possible swing range there will be an estimated 9.03% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $40.74 (4.17%) than the support at $37.02 (5.34%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Ultragenyx Pharmaceutical Inc. stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Ultragenyx Pharmaceutical Inc. stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 1.419 Open Broker Account

Remember To Visit Our YouTube Channel